Renaissance Group LLC Increases Stake in HealthEquity, Inc. (NASDAQ:HQY)

Renaissance Group LLC lifted its holdings in shares of HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 11.5% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 46,740 shares of the company's stock after purchasing an additional 4,838 shares during the period. Renaissance Group LLC owned about 0.05% of HealthEquity worth $4,486,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Arcadia Investment Management Corp MI bought a new position in HealthEquity during the fourth quarter valued at $26,000. Smartleaf Asset Management LLC lifted its position in shares of HealthEquity by 34.3% during the 4th quarter. Smartleaf Asset Management LLC now owns 384 shares of the company's stock valued at $37,000 after buying an additional 98 shares during the last quarter. Proficio Capital Partners LLC purchased a new position in shares of HealthEquity during the 4th quarter valued at $39,000. UMB Bank n.a. grew its stake in shares of HealthEquity by 65.6% during the 4th quarter. UMB Bank n.a. now owns 414 shares of the company's stock worth $40,000 after acquiring an additional 164 shares during the period. Finally, Skandinaviska Enskilda Banken AB publ increased its holdings in HealthEquity by 1,934.8% in the 4th quarter. Skandinaviska Enskilda Banken AB publ now owns 468 shares of the company's stock worth $45,000 after acquiring an additional 445 shares during the last quarter. 99.55% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several equities research analysts have commented on HQY shares. Barrington Research reaffirmed an "outperform" rating and set a $112.00 price objective on shares of HealthEquity in a report on Friday. The Goldman Sachs Group cut their price objective on shares of HealthEquity from $107.00 to $94.00 and set a "neutral" rating for the company in a report on Thursday, March 27th. Wells Fargo & Company lifted their price objective on shares of HealthEquity from $110.00 to $125.00 and gave the company an "overweight" rating in a research note on Wednesday, February 26th. KeyCorp dropped their target price on HealthEquity from $120.00 to $110.00 and set an "overweight" rating on the stock in a research report on Monday, March 24th. Finally, Raymond James upgraded HealthEquity from an "outperform" rating to a "strong-buy" rating and reduced their price target for the company from $120.00 to $115.00 in a research report on Tuesday, March 25th. One research analyst has rated the stock with a hold rating, ten have issued a buy rating and one has assigned a strong buy rating to the company's stock. According to data from MarketBeat, HealthEquity has a consensus rating of "Buy" and a consensus target price of $112.58.

Remove Ads

HealthEquity Price Performance

Shares of NASDAQ:HQY traded up $2.26 on Friday, hitting $82.20. The company's stock had a trading volume of 926,462 shares, compared to its average volume of 760,765. The company has a market capitalization of $7.11 billion, a PE ratio of 75.41, a PEG ratio of 1.60 and a beta of 0.49. The company has a debt-to-equity ratio of 0.51, a current ratio of 3.20 and a quick ratio of 3.20. The company has a 50-day simple moving average of $97.63 and a 200 day simple moving average of $96.42. HealthEquity, Inc. has a 1 year low of $65.01 and a 1 year high of $115.59.

Insider Buying and Selling

In related news, EVP Michael Henry Fiore sold 8,881 shares of the company's stock in a transaction on Friday, April 4th. The shares were sold at an average price of $78.26, for a total value of $695,027.06. Following the completion of the transaction, the executive vice president now directly owns 56,655 shares in the company, valued at approximately $4,433,820.30. The trade was a 13.55 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Robert W. Selander sold 5,750 shares of the firm's stock in a transaction dated Wednesday, April 9th. The shares were sold at an average price of $77.65, for a total value of $446,487.50. Following the sale, the director now owns 84,969 shares in the company, valued at $6,597,842.85. The trade was a 6.34 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 20,381 shares of company stock worth $1,781,432. Insiders own 2.20% of the company's stock.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.